Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
David L. Green, MD, PhD, MBA, founder and CEO of R3 Stem Cell International, discusses stem cell therapy for kidney failure in South Africa. He explains the function…
Dawn L. Sammons, DO; Joslyn R. Sciacca Kirby, MD, MS; Boni E. Elewski, MD; and David M. Pariser, MD, provide clinical and therapeutic #pearls in medical #dermatology.
